NR 508 (NR 508)
Kaplan University
Aquí están los mejores recursos para pasar NR 508 (NR 508). Encuentra NR 508 (NR 508) guías de estudio, notas, tareas, y mucho más.
11 resultados
Examen
NR 508 - Week 7 Exam
NR 508 - Week 7 Exam /NR 508 - Week 7 Exam. 
Digoxin levels need to be monitored closely when the following medication is started: 
4. Albuterol 
Patients with pheochromocytoma should avoid which of the following classes of drugs because of the possibility of developing hypertensive crisis? 
2. Beta-2-agonists 
Harold, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all? 
2. Salmeterol, an inhaled long-act...
Examen
Grand Rounds Osteoarthritis Week6 case study
PopularGrand Rounds Osteoarthritis Week6 case study/Grand Rounds Osteoarthritis Week6 case study
Examen
Nr 508 Nr508 Advanced Pharm Exam 3 Questions And Answers (100% Verified)
Questions And Answers
Examen
nr test bank pharmacology Prescriptive Authority and Role Implementation: Tradition vs. Change Test Bank
Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs. Change 
Test Bank 
MULTIPLE CHOICE 
1. Which of the following has influenced an emphasis on primary care education in medical 
schools? 
a. Changes in Medicare reimbursement 
methods recommended in 1992 
b. Competition from nonphysicians desiring 
to meet primary care shortages 
c. The need for monopolistic control in the 
marketplace of primary outpatient care 
d. The recognition that nonphysicians have 
variable suc...
Examen
NR 508-Pharmacology Mid-term questions and answers
NR 508-Pharmacology Mid-term questions and answers
Examen
NR 508 Midterm Exam - Advanced Pharm with Answers (100% CORRECT)
1. A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: 
 
2. A patient who has hyperlipidemia has been taking atorvastatin (Lipitor) 60 mg daily for 6 months. The patient’s initial lipid profile showed LDL of 180 mg/dL, HDL of 45 m...
Examen
NR 508 - Week 5 Exam.//Exam (elaborations) NR 508 (NR508WEEK5EXAM.) (NR 508 (NR508WEEK5EXAM.))
NR 508 | NR508 Week 5 
 
Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: 
1. Cortical bones 
2. Femoral neck bones 
3. Cervical vertebrae 
4. Pelvic bones 
2. Femoral neck bones 
Bisphosphonates treat or prevent osteoporosis by: 
1. Inhibiting osteoclastic activity 
2. Fostering bone resorption 
3. Enhancing calcium uptake in the bone 
4. Strengthening the osteoclastic proton pump 
1. Inhibiting osteoclastic activity 
Prophylactic us...
Examen
Nr508 Midterm Study Guide(Latest Version)
Nr508 Midtermnr508 Midterm Study Guide
Resumen
NR 508 | NR508 Advanced Pathophysiology- Endocrine Study guide.
NR 508 | NR508 Advanced Pathophysiology- Endocrine Study guide.
Examen
NR 508 - Week 5 Exam.
NR 508 - Week 5 Exam/NR 508 - Week 5 Exam. 
Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: 
Bisphosphonates treat or prevent osteoporosis by:
Examen
Nr 508 - Advanced Pharm Possible Midterm Questions And Answers (Version 3).
NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3)/NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3). 
A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: